Irina Staatz-Granzer, Vice Chairman and member of the Supervisory Board, has served on our Supervisory Board since 2009.
Ms. Staatz-Granzer has held business development positions at Hermal, Boots Healthcare International, Knoll, Scil Biomedicals and as CEO of Scil Technology. Ms. Staatz-Granzer also serves as Chairman of Blink Therapeutics and Blink Biomedicals, as Vice President of PLCD (German Pharma Licensing Club) and CEO of U3 Pharma.
She founded and is currently CEO of Staatz Business Development & Strategy.
Ms. Staaz-Granzer received a degree in pharmacy from Philipps-Universität Marburg and a Ph.D. from the University of Tübingen.